cefcanel daloxate has been researched along with Bacterial Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Köhler, W; Schenk, P | 1 |
| Lionell, C; Magni, L | 1 |
| Hashizume, H; Nishino, T; Obana, Y; Yoshimi, A | 1 |
1 trial(s) available for cefcanel daloxate and Bacterial Disease
| Article | Year |
|---|---|
[Cephalosporin treatment of maxillary sinusitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Double-Blind Method; Female; Haemophilus Infections; Humans; Male; Maxillary Sinusitis; Middle Aged; Prodrugs | 1995 |
2 other study(ies) available for cefcanel daloxate and Bacterial Disease
| Article | Year |
|---|---|
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |
In vitro and in vivo antibacterial activity of KY-109, a new orally active cephalosporin.
Topics: Administration, Oral; Animals; Bacterial Infections; Cephalosporins; Male; Mice; Microbial Sensitivity Tests; Rabbits; Rats; Rats, Inbred Strains; Urinary Tract Infections | 1988 |